SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001136261-15-000049
Filing Date
2015-02-18
Accepted
2015-02-18 16:16:41
Documents
13
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K form10k.htm 10-K 1148623
2 STATEMENT REGARDING COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES exh12-1.htm EX-12.1 21370
3 SUBSIDIARIES exh21-1.htm EX-21.1 2218
4 CONSENT exh23-1.htm EX-23.1 1583
5 CEO CERTIFICATE exh31-1.htm EX-31.1 6613
6 CFO CERTIFICATE exh31-2.htm EX-31.2 6636
7 906 CERTIFICATE exh32.htm EX-32 2898
  Complete submission text file 0001136261-15-000049.txt   7236801

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT npsp-20141231.xml EX-101.INS 925100
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT npsp-20141231.xsd EX-101.SCH 76661
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT npsp-20141231_cal.xml EX-101.CAL 97512
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT npsp-20141231_def.xml EX-101.DEF 135635
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT npsp-20141231_lab.xml EX-101.LAB 447738
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT npsp-20141231_pre.xml EX-101.PRE 333726
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23272 | Film No.: 15628176
SIC: 2836 Biological Products, (No Diagnostic Substances)